Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.50 |
| ▸ | SCN4A | P35499 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17800997 | 0.81 | IDO1 (0.75) | LTA4HCYP3A4CYP1A2CYP2D6IDO1 | |
| SCHEMBL871045 | 0.79 | IDO1 (0.58) | LTA4HCYP3A4CYP1A2CYP2D6IDO1 | |
| SCHEMBL872238 | 0.78 | IDO1 (0.64) | LTA4HCYP3A4CYP1A2CYP2D6IDO1 | |
| SCHEMBL14129973 | 0.78 | CYP2D6 (1.00) | LTA4HCYP3A4CYP1A2CYP2D6ASIC3 | |
| SCHEMBL28238890 | 0.77 | CYP17A1 (0.52) | CYP3A4IDO1ASIC3POLBSMN1; SMN2 | |
| SCHEMBL13030725 | 0.77 | POLB (0.79) | LTA4HCYP3A4CYP1A2CYP2D6IDO1 | |
| SCHEMBL29578589 | 0.77 | CYP17A1 (0.52) | CYP3A4IDO1ASIC3POLBSMN1; SMN2 | |
| SCHEMBL30590469 | 0.77 | LTA4H (0.58) | LTA4HCYP3A4CYP1A2CYP2D6IDO1 | |
| SCHEMBL27880327 | 0.75 | IDO1 (0.67) | LTA4HCYP3A4CYP1A2CYP2D6IDO1 | |
| SCHEMBL30026881 | 0.74 | IDO1 (0.47) | CYP3A4CYP1A2CYP2D6IDO1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084055-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | US | disclosed |
| US-12091397-B2 | Dihydroquinolinones for medical treatment | C4 THERAPEUTICS, INC. | 2024-09-17 | — | — | US | disclosed |
| CN-111278816-B | Dihydro quinolinones | C4医药公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20230192643-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| US-11401256-B2 | Dihydroquinolinones for medical treatment | C4 THERAPEUTICS, INC. (US) | 2022-08-02 | — | — | US | disclosed |
| EP-3679028-A1 | DIHYDROQUINOLINONES | C4 Therapeutics, Inc. (US) | 2020-07-15 | — | — | EP | disclosed |
| US-20200207733-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2020-07-02 | — | — | US | disclosed |
| CN-111278816-A | Dihydroquinolinones | C4医药公司 | 2020-06-12 | — | — | CN | disclosed |
| EP-3032625-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2020-01-08 | — | — | EP | disclosed |
| WO-2019043208-A1 | DIHYDROQUINOLINONES | F. HOFFMANN-LA ROCHE AG (CH) | 2019-03-07 | — | — | WO | disclosed |
| EP-2458667-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2017-05-24 | — | — | EP | disclosed |
| EP-2763223-B1 | POROUS SEPARATOR FOR FUEL CELLS | NISSHINBO CHEMICAL INC (JP) | 2016-11-16 | — | — | EP | disclosed |
| EP-3032625-A1 | FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2016-06-15 | — | — | EP | disclosed |
| US-20160156044-A1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC. (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-2763223-A1 | POROUS SEPARATOR FOR FUEL CELLS | Nisshinbo Chemical Inc. (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-8372192-B2 | Fuel cell separator | NISSHINBO CHEMICAL INC. (JP) | 2013-02-12 | — | — | US | disclosed |
| EP-2458667-A1 | FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-8182975-B2 | Positive resist composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20120077111-A1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC. (JP) | 2012-03-29 | — | — | US | disclosed |
| US-20080248419-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12091397-B2 | Dihydroquinolinones for medical treatment | CRBN, RBX1, ADRM1 | LTA4H 4221/4885CYP3A4 4686/4885CYP1A2 4657/4885 |
| US-20230192643-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | CRBN, RBX1, ADRM1 | LTA4H 4221/4885CYP3A4 4686/4885CYP1A2 4657/4885 |
| US-20250084055-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | CRBN, RBX1, ADRM1 | LTA4H 4221/4885CYP3A4 4686/4885CYP1A2 4657/4885 |
| US-20200207733-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | CRBN, RBX1, ADRM1 | LTA4H 4221/4885CYP3A4 4686/4885CYP1A2 4657/4885 |
| US-11401256-B2 | Dihydroquinolinones for medical treatment | CRBN, RBX1, ADRM1 | LTA4H 4221/4885CYP3A4 4686/4885CYP1A2 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.